Economics Faculty Database
Economics
Arts & Sciences
Duke University

 HOME > Arts & Sciences > Economics > Faculty    Search Help Login pdf version printable version 

David B. Ridley, Professor of the Practice and Economics and Associate of the Duke Initiative for Science & Society and Executive Core Faculty Member, Duke-Margolis Center for Health Policy of Duke - Margolis Center For Health Policy

David B. Ridley

David Ridley is the Faculty Director of Health Sector Management at Duke University’s Fuqua School of Business. In his research, he examines innovation and pricing in health care. David was the lead author of the paper proposing the priority review voucher program which became law in 2007 and created a market of more than a billion dollars for drug development for neglected diseases. He was the principal investigator on a grant from the Bill & Melinda Gates Foundation for 2018 to 2020. He teaches courses on health care economics, policy, and strategy to graduate students. He received a PhD in economics from Duke University.

Contact Info:
Office Location:  100 Fuqua Drive, Durham, NC 27708-0120
Email Address: send me a message
Web Pages:  http://www.fuqua.duke.edu/faculty/david-ridley
https://sites.duke.edu/ridley/

Teaching (Summer2 2021):

  • QM 726QH.301, HEALTHCAREINSTITUTIONS&POLICY3 Synopsis
    TBA, -
Education:

Ph.D.Duke University2001
M.A.Duke University1995
B.A.University of Missouri, Columbia1993
Specialties:

Health Economics
Industrial Organization
Research Interests:

David Ridley is the Dr. and Mrs. Frank A. Riddick Professor of the Practice of Business. He is also the Faculty Director of Duke's Health Sector Management program. In his research, David examines innovation and pricing, especially in health care. He was the lead author of the paper proposing the priority review voucher program The voucher program became law in the U.S. in 2007 and the market price of vouchers has been more than $100 million. David has published in economics journals (American Economic Journal: Economic Policy), medical journals (Journal of the American Medical Association), and scientific journals (Nature Reviews Drug Discovery). David teaches in the daytime MBA and executive MBA programs. He received a PhD in economics from Duke University in 2001.

Areas of Interest:

Health Economics
Industrial Organization
Strategy

Keywords:

Biotechnology • Drug Approval • Drug Costs • Drug Industry • Economics, Pharmaceutical • Elasticity • Health Care Costs • Health Care Economics and Organizations • Health Care Reform • Health Care Sector • Health Policy • Health Services Research • Innovation • Market entry • Patents as Topic • Prescription Fees • Pricing • Product Surveillance, Postmarketing • World Health Organization

Curriculum Vitae
Recent Publications   (More Publications)   (search)

  1. Ridley, DB; Lee, CY, Does medicare reimbursement drive up drug launch prices?, The Review of Economics and Statistics, vol. 102 no. 5 (December, 2020), pp. 980-993 [doi]  [abs]
  2. Kyle, MK; Ridley, DB; Zhang, S, Strategic interaction among governments in the provision of a global public good, Journal of Public Economics, vol. 156 (December, 2017), pp. 185-199, Elsevier BV [doi]  [abs]
  3. Ridley, DB; Moe, JL; Hamon, N, A Voucher System To Speed Review Could Promote A New Generation Of Insecticides To Fight Vector-Borne Diseases., Health Affairs, vol. 36 no. 8 (August, 2017), pp. 1461-1468 [doi]  [abs]
  4. Yurukoglu, A; Liebman, E; Ridley, DB, The role of government reimbursement in drug shortages, American Economic Journal: Economic Policy, vol. 9 no. 2 (May, 2017), pp. 348-382, American Economic Association [doi]  [abs]
  5. Ridley, DB; Zhang, S, Regulation of price increases, International Journal of Industrial Organization, vol. 50 (January, 2017), pp. 186-213, Elsevier BV [doi]  [abs]


Duke University * Arts & Sciences * Economics * Faculty * Research * Staff * Master's * Ph.D. * Reload * Login